US$ 25.69
novo nordisk oral semaglutide to Seek Approval for Pill to Treat Diabetes in Young Patients Novo Nordisk's weight-loss pill wins
Description
UpToDate Lexidrug
Patients should continue with lifestyle modifications, including a balanced diet and regular physical activity, to maximise cardiovascular health alongside pharmacological treatment

doi: 10.1016/j.clnu.2020.04.005 56 HuJ.LinS.ZhengB.CheungP
Brain 146 (6), 22752284

The Key to Sustainable Weight Loss Many people lose weight with semaglutide and other GLP-1 medications, but keeping it off requires more than just taking a shot or a pill
The triple-action mechanism might require different dose adjustments compared to dual agonists
